Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease, or cirrhosis. Nat Rev Gastroenterol Hepatol. 2013;10:330–44.

Article  CAS  PubMed  Google Scholar 

Tokushige K, Hyogo H, Nakajima T, et al. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey. J Gastroenterol. 2016;51:586–96.

Article  CAS  PubMed  Google Scholar 

Lonardo A, Nascimbeni F, Mantovani A, et al. Hypertension, diabetes, atherosclerosis, and NASH: Cause or consequence? J Hepatol. 2018;68:335–52.

Article  PubMed  Google Scholar 

Niwa H, Sasaki M, Haratake J, et al. Clinicopathological significance of antinuclear antibodies in non-alcoholic steatohepatitis. Hepatol Res. 2007;37:923–31.

Article  PubMed  Google Scholar 

Adams LA, Lindor KD, Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. Am J Gastroenterol. 2004;99:1316–20.

Article  CAS  PubMed  Google Scholar 

Woods CP, Hazlehurst JM, Tomlinson JW. Glucocorticoids and non-alcoholic fatty liver disease. J Steroid Biochem Mol Biol. 2015;154:94–103.

Article  CAS  PubMed  Google Scholar 

Komura T, Ohta H, Seike T, et al. The efficacy of corticosteroid therapy in a patient with non-alcoholic steatohepatitis overlapping autoimmune hepatitis. Intern Med. 2018;57:807–12.

Article  PubMed  Google Scholar 

Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association. Hepatology. 2012;55:2005–23.

Article  PubMed  Google Scholar 

Sutti S, Albano E. Adaptive immunity: an emerging player in the progression of NAFLD. Nat Rev Gastroenterol Hepatol. 2020;17:81–92.

Article  CAS  PubMed  Google Scholar 

Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol. 2022;22:429–43.

Article  CAS  PubMed  Google Scholar 

Younes R, Govaere O, Petta S, et al. Presence of serum antinuclear antibodies does not impact long-term outcomes in nonalcoholic fatty liver disease. Am J Gastroenterol. 2020;115:1289–92.

Article  PubMed  Google Scholar 

Kado A, Tsutsumi T, Enooku K, et al. Noninvasive diagnostic criteria for nonalcoholic steatohepatitis based on gene expression levels in peripheral blood mononuclear cells. J Gastroenterol. 2019;54:730–41.

Article  CAS  PubMed  Google Scholar 

Ajmera V, Perito ER, Bass NM, et al. NASH clinical research network. novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease. Hepatology. 2017;65:65–77.

Article  CAS  PubMed  Google Scholar 

Tamaki N, Kurosaki M, Huang DQ, et al. Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease. Hepatol Res. 2022;52:497–507.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kamada Y, Nakamura T, Isobe S, et al. JANIT forum SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT forum. J Gastroenterol. 2023;58:79–97.

Article  PubMed  Google Scholar 

Ugarte-Gil MF, Sánchez-Zúñiga C, Gamboa-Cárdenas RV, et al. Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients. Lupus. 2016;25:233–40.

Article  CAS  PubMed  Google Scholar 

Seike T, Mizukoshi E, Yamada K, et al. Fatty acid-driven modifications in T-cell profiles in non-alcoholic fatty liver disease patients. J Gastroenterol. 2020;55:701–11.

Article  CAS  PubMed  Google Scholar 

Lin SZ, Fan JG. Peripheral immune cells in NAFLD patients: a spyhole to disease progression. EBioMedicine. 2022;75: 103768.

Article  CAS  PubMed  Google Scholar 

Renand A, Cervera-Marzal I, Gil L, et al. Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis. J Hepatol. 2020;73:1379–90.

Article  CAS  PubMed  Google Scholar 

Cueto-Sanchez A, Niu H, Del Campo-Herrera E, et al. Lymphocyte profile and immune checkpoint expression in drug-induced liver injury: An immunophenotyping study. Clin Pharmacol Ther. 2021;110:1604–12.

Article  CAS  PubMed  Google Scholar 

Peiseler M, Sebode M, Franke B, et al. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency. J Hepatol. 2012;57:125–32.

Article  CAS  PubMed  Google Scholar 

Vonghia L, Magrone T, Verrijken A, et al. Peripheral and hepatic vein cytokine levels in correlation with non-alcoholic fatty liver disease (NAFLD)-related metabolic, histological, and haemodynamic features. PLoS ONE. 2015;10: e0143380.

Article  PubMed  PubMed Central  Google Scholar 

Strzepka J, Schwartz BA, Ritz EM, et al. Patients With Autoimmune Hepatitis and Nonalcoholic Fatty Liver Disease: Characteristics, Treatment, and Outcomes. J Clin Gastroenterol. 2022.

Abe K, Fujita M, Hayashi M, et al. Association of serum 25-hydroxyvitamin D levels with severe necroinflammatory activity and inflammatory cytokine production in type I autoimmune hepatitis. PLoS ONE. 2020;15: e0239481.

Article  CAS  PubMed  PubMed Central  Google Scholar 

European Association for the Study of the Liver. EASL clinical practice guidelines: autoimmune hepatitis. J Hepatol. 2015;63:971–1004.

Article  Google Scholar 

Takahashi A, Arinaga-Hino T, Ohira H, et al (2017); Autoimmune Hepatitis Study Group-Subgroup of the Intractable Hepato-Biliary Disease Study Group in Japan. Autoimmune hepatitis in Japan: trends in a nationwide survey. J Gastroenterol 52: 631–640.

Hu S, Zhao F, Wang Q, et al. The accuracy of the anti-mitochondrial antibody and the M2 subtype test for diagnosis of primary biliary cirrhosis: A meta-analysis. Clin Chem Lab Med. 2014;52:1533–42.

Article  CAS  PubMed  Google Scholar 

Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–9.

Article  CAS  PubMed  Google Scholar 

Kleiner DE, Brunt EM, Wilson LA, et al; Nonalcoholic Steatohepatitis Clinical Research Network. Association of histologic disease activity with progression of nonalcoholic fatty liver disease. JAMA Netw Open. 2019; 2: e1912565.

Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.

Article  CAS  PubMed  Google Scholar 

Tiniakos DG, Brain JG, Bury YA. Role of histopathology in autoimmune hepatitis. Dig Dis. 2015;33:53–64.

Article  PubMed  Google Scholar 

Tanaka A, Notohara K. Immunoglobulin G4 (IgG4)-related autoimmune hepatitis and IgG4-hepatopathy: a histopathological and clinical perspective. Hepatol Res. 2021;51:850–9.

Article  CAS  PubMed  Google Scholar 

Tsuneyama K, Baba H, Kikuchi K, et al. Autoimmune features in metabolic liver disease: a single-center experience and review of the literature. Clin Rev Allergy Immunol. 2013;45:143–8.

Article  CAS  PubMed  Google Scholar 

Hansel C, Erschfeld S, Baues M, et al. The inhibitory T cell receptors PD1 and 2B4 are differentially regulated on CD4 and CD8 T cells in a mouse model of non-alcoholic steatohepatitis. Front Pharmacol. 2019;10:244.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bergeron M, Nicholson JK, Phaneuf S, et al. Selection of lymphocyte gating protocol has an impact on the level of reliability of T-cell subsets in aging specimens. Cytometry. 2002;50:53–61.

Article  CAS  PubMed  Google Scholar 

Huang LQ, Wang JX, He K, et al. Analysis of peripheral blood T-cell subsets and regulatory T-cells in multiple myeloma patients. Cell Mol Biol. 2018;64(5):113–7.

Article  PubMed  Google Scholar 

Raphael I, Nalawade S, Eagar TN, et al. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 2015;74:5–17.

Article  CAS  PubMed  Google Scholar 

Wang SR, Zhong N, Zhang XM, et al. OMIP 071: A 31-parameter flow cytometry panel for in-depth immunophenotyping of human T-cell subsets using surface markers. Cytometry A. 2021;99:273–7.

Article  PubMed  Google Scholar 

Wang H, Feng X, Yan W, et al. Regulatory T cells in autoimmune hepatitis: Unveiling their roles in mouse models and patients. Front Immunol. 2020;11: 575572.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang B, Chikuma S, Hori S, et al. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model. Proc Natl Acad Sci U S A. 2016;113:8490–5.

Article  CAS  PubMed